For the Inventor, By the Inventor

Enter assignee name

Gyeonggi-Do, South Korea

Qurient Co., Ltd.

USPTO Granted Patents = 4

Forward Citations = 0

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Kiyean Nam (4 out of 11 patents)

Jaeseung Kim (4 out of 17 patents)

Yeejin Jeon (2 out of 7 patents)

4. Dongsik Park (2 out of 8 patents)

5. Mooyoung Seo (2 out of 7 patents)

6. Donghoon Yu (2 out of 4 patents)

7. Chunwon Jung (2 out of 2 patents)

8. Uwe Koch (1 out of 19 patents)

9. SaeYeon Lee (1 out of 7 patents)

10. Jan Eickhoff (1 out of 9 patents)

11. Gunther Zischinsky (1 out of 10 patents)

12. Jiyoong Chun (1 out of 1 patent)

13. Borami Jeon (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12698288 - Compounds having cyclin-dependent kinase(CDK)-inhibitory function (2026-08-04),

2. 12653787 - Pharmaceutical oral dosage form of Q203 (2026-06-16),

3. 12606561 - Substituted pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors (2026-04-21),

4. 12582598 - Topical anti-inflammatory pharmaceutical composition comprising Zileuton (2026-03-24),

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#148 in Gyeonggi-Do

#2,187 in South Korea

Gyeonggi-Do, South Korea

Qurient Co., Ltd.

Forward Citations = 0

13 inventors:

Kiyean Nam (4 out of 11 patents)

Jaeseung Kim (4 out of 17 patents)

Yeejin Jeon (2 out of 7 patents)

4. Dongsik Park (2 out of 8 patents)

5. Mooyoung Seo (2 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…